DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Tyramine is an investigational drug.
There have been 18 clinical trials for Tyramine. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2016.
The most common disease conditions in clinical trials are Hypercholesterolemia, Depression, and Hyperlipoproteinemia Type II. The leading clinical trial sponsors are Sanofi, Regeneron Pharmaceuticals, and Yonsei University.
Recent Clinical Trials for Tyramine
|A Clinical Study to Assess the Effect of Change of Bile Acid on the PD and Safety of Metformin and Microbiome Profiles||Seoul National University Hospital||N/A|
|Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease||EA Pharma Co., Ltd.||Phase 2|
|Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease||Yokohama City University||Phase 2|